Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Viatris Inc (VTRS)

Viatris Inc (VTRS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
7.36 -0.25 (-3.29%) 04/08/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 7.50 +0.14 (+1.90%) 19:55 ET
Quote Overview for Tue, Apr 8th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.21
Day High
7.99
Open 7.84
Previous Close 7.61 7.61
Volume 15,567,500 15,567,500
Avg Vol 16,299,320 16,299,320
Stochastic %K 9.77% 9.77%
Weighted Alpha -45.03 -45.03
5-Day Change -1.24 (-14.42%) -1.24 (-14.42%)
52-Week Range 7.14 - 13.55 7.14 - 13.55
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,083,973
  • Shares Outstanding, K 1,193,689
  • Annual Sales, $ 14,739 M
  • Annual Income, $ -634,200 K
  • EBIT $ 10 M
  • EBITDA $ 2,903 M
  • 60-Month Beta 0.91
  • Price/Sales 0.62
  • Price/Cash Flow 1.49
  • Price/Book 0.49

Options Overview Details

View History
  • Implied Volatility 63.53% ( +3.01%)
  • Historical Volatility 56.34%
  • IV Percentile 99%
  • IV Rank 87.09%
  • IV High 69.86% on 04/04/25
  • IV Low 20.82% on 11/13/24
  • Put/Call Vol Ratio 0.50
  • Today's Volume 9,081
  • Volume Avg (30-Day) 3,106
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 116,835
  • Open Int (30-Day) 107,053

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.52
  • Number of Estimates 3
  • High Estimate 0.56
  • Low Estimate 0.49
  • Prior Year 0.67
  • Growth Rate Est. (year over year) -22.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.14 +3.08%
on 04/07/25
Period Open: 9.65
9.73 -24.32%
on 03/10/25
-2.29 (-23.73%)
since 03/07/25
3-Month
7.14 +3.08%
on 04/07/25
Period Open: 11.96
12.02 -38.77%
on 01/14/25
-4.60 (-38.46%)
since 01/08/25
52-Week
7.14 +3.08%
on 04/07/25
Period Open: 11.75
13.55 -45.68%
on 11/25/24
-4.39 (-37.36%)
since 04/08/24

Most Recent Stories

More News
How Is Viatris’ Stock Performance Compared to Other Biotech Stocks?

Over the past six months, Viatris has lagged behind its biotech peers, and Wall Street analysts continue to exercise caution regarding the stock's future outlook.

VTRS : 7.36 (-3.29%)
IBBQ : 18.67 (-2.81%)
PRGO : 24.55 (-5.72%)
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

ELAN : 8.33 (-6.82%)
JAZZ : 102.82 (-3.84%)
VTRS : 7.36 (-3.29%)
ZTS : 144.41 (-3.15%)
ANIP : 63.05 (-5.88%)
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

VTRS : 7.36 (-3.29%)
AMPH : 23.75 (-5.00%)
ANIP : 63.05 (-5.88%)
AMRX : 6.99 (-3.05%)
1 Healthcare Stock to Target This Week and 2 to Turn Down

1 Healthcare Stock to Target This Week and 2 to Turn Down

PACB : 1.2000 (-9.09%)
VTRS : 7.36 (-3.29%)
BMRN : 55.89 (-5.53%)
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

VTRS : 7.36 (-3.29%)
ANIP : 63.05 (-5.88%)
AMPH : 23.75 (-5.00%)
AMRX : 6.99 (-3.05%)
Chip Stock Weakness and Tariff Angst Sink Stocks

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -1.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.45% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.75%. March E-mini...

AMAT : 128.96 (-2.93%)
AXON : 504.03 (+0.29%)
$IUXX : 17,090.40 (-1.95%)
UNH : 553.08 (+5.41%)
ELV : 430.90 (+1.83%)
ZNM25 : 110-135 (-0.94%)
PSTG : 38.69 (+0.49%)
ESM25 : 4,936.00 (-1.68%)
PZZA : 32.14 (-8.56%)
GFS : 30.37 (-5.71%)
VTRS : 7.36 (-3.29%)
WBA : 10.59 (-1.12%)
Why Viatris (VTRS) Shares Are Falling Today

Why Viatris (VTRS) Shares Are Falling Today

VTRS : 7.36 (-3.29%)
Nasdaq Slumps on Nvidia Weakness as Tariff Anxieties Loom Large

The S&P 500 Index ($SPX ) (SPY ) today is down -1.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.35%. March E-mini S&P futures...

AMAT : 128.96 (-2.93%)
AXON : 504.03 (+0.29%)
$IUXX : 17,090.40 (-1.95%)
ELV : 430.90 (+1.83%)
ZNM25 : 110-135 (-0.94%)
PSTG : 38.69 (+0.49%)
ESM25 : 4,936.00 (-1.68%)
PZZA : 32.14 (-8.56%)
GFS : 30.37 (-5.71%)
WBA : 10.59 (-1.12%)
VTRS : 7.36 (-3.29%)
WBD : 7.69 (-4.94%)
Viatris Misses Estimates, Cash Flow Up

Viatris reported mixed results for Q4 2024, missing revenue and EPS expectations, despite noteworthy debt reduction and portfolio adjustments.

VTRS : 7.36 (-3.29%)
Stocks Give Up Early Gains on Tariff Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.79%. March E-mini S&P futures (ESH25...

AXON : 504.03 (+0.29%)
$IUXX : 17,090.40 (-1.95%)
ELV : 430.90 (+1.83%)
ZNM25 : 110-135 (-0.94%)
TSLA : 221.86 (-4.90%)
PSTG : 38.69 (+0.49%)
ESM25 : 4,936.00 (-1.68%)
PZZA : 32.14 (-8.56%)
VTRS : 7.36 (-3.29%)
WBD : 7.69 (-4.94%)
$DOWI : 37,645.59 (-0.84%)
SPY : 496.48 (-1.57%)
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow

Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow

VTRS : 7.36 (-3.29%)
SUPN : 30.64 (-5.05%)
AMRX : 6.99 (-3.05%)
Viatris: Q4 Earnings Snapshot

Viatris: Q4 Earnings Snapshot

VTRS : 7.36 (-3.29%)
Viatris (NASDAQ:VTRS) Misses Q4 Revenue Estimates, Stock Drops

Viatris (NASDAQ:VTRS) Misses Q4 Revenue Estimates, Stock Drops

VTRS : 7.36 (-3.29%)
Viatris Earnings: What To Look For From VTRS

Viatris Earnings: What To Look For From VTRS

JAZZ : 102.82 (-3.84%)
VTRS : 7.36 (-3.29%)
SUPN : 30.64 (-5.05%)
Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

VTRS : 7.36 (-3.29%)
ANIP : 63.05 (-5.88%)
AMPH : 23.75 (-5.00%)
AMRX : 6.99 (-3.05%)
Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

VTRS : 7.36 (-3.29%)
ANIP : 63.05 (-5.88%)
AMPH : 23.75 (-5.00%)
AMRX : 6.99 (-3.05%)
3 Reasons to Sell VTRS and 1 Stock to Buy Instead

3 Reasons to Sell VTRS and 1 Stock to Buy Instead

TDG : 1,231.75 (-1.42%)
VTRS : 7.36 (-3.29%)
Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

VTRS : 7.36 (-3.29%)
AMPH : 23.75 (-5.00%)
ANIP : 63.05 (-5.88%)
AMRX : 6.99 (-3.05%)
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

VTRS : 7.36 (-3.29%)
ANIP : 63.05 (-5.88%)
AMPH : 23.75 (-5.00%)
AMRX : 6.99 (-3.05%)
Viatris Stock Outlook: Is Wall Street Bullish or Bearish?

As Viatris has trailed the broader market over the past year, analysts are skeptical about its future outlook.

XPH : 36.82 (-4.06%)
$SPX : 4,982.77 (-1.57%)
VTRS : 7.36 (-3.29%)
PIPR : 210.78 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor...

See More

Key Turning Points

3rd Resistance Point 8.61
2nd Resistance Point 8.30
1st Resistance Point 7.83
Last Price 7.36
1st Support Level 7.05
2nd Support Level 6.74
3rd Support Level 6.27

See More

52-Week High 13.55
Fibonacci 61.8% 11.10
Fibonacci 50% 10.35
Fibonacci 38.2% 9.59
Last Price 7.36
52-Week Low 7.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.